Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Venus Remedies Ltd.

Price on BSE   13 May,15:24 LIVE
920.05
-9.20
(-0.99%)

© 2026 Rediff.com
  • Volume :
  • 2,163.00
  • Prev Close :
  • 929.25
  • Day's H/L (Rs.) :
  • 952.70 - 915.00
  • 52wk H/L (Rs.) :
  • 1,119.00 - 306.00
  • Mkt Cap (Rs. Cr) :
  • 1,232.87
Price on NSE   13 May,15:47 LIVE
922.55
-9.15
(-0.98%)

© 2026 Rediff.com
  • Volume :
  • 41,099.00
  • Prev Close :
  • 931.70
  • Day's H/L (Rs.) :
  • 956.40 - 913.50
  • 52wk H/L (Rs.) :
  • 1,088.80 - 305.00
  • Mkt Cap (Rs. Cr) :
  • 0.00
Report Card - Venus Remedies Ltd.
PE Ratios
23.61
EPS (Rs.)
39.30
Sales (Rs. Cr)
179.95
Face Value (Rs.)
10
Net Profit Margin(%)
8.21
Last Bonus
-
Last Dividend(%)
30
Return on Average Equity
8.91

News for Venus Remedies Ltd.

Venus Remedies Antibiotic Approved in Argentina
Venus Remedies secures marketing approval in Argentina for Ceftriaxone, an antibiotic to treat bacterial infections. Expands Latin America presence.
May 07, 2026 12:00
Venus Remedies: Drugs Approved in Vietnam
Venus Remedies secures marketing authorisations for Methotrexate, Cefuroxime, Irinotecan in Vietnam. Expands export footprint in South Asia.
Nov 09, 2025 12:22
Venus Remedies Renews Ukrainian GMP Certification
Venus Remedies has renewed its GMP certification from Ukraine's State Service on Medicines and Drugs Control (SMDC), reinforcing its position in the Ukrainian market and expanding its reach into...
May 24, 2025 10:37
Venus Remedies Gets Marketing Nod for Sugammadex in Philippines
Venus Remedies receives marketing authorisation for Sugammadex in the Philippines, marking a major step in its expansion into complex generics and the ASEAN market. Sugammadex is a relaxant-binding...
Mar 04, 2025 13:05
Venus Remedies Partners with UK Firm to Develop MET-X for Drug-Resistant Infections
Venus Remedies has partnered with Infex Therapeutics to develop MET-X, an innovative metallo-beta-lactamase inhibitor, to tackle drug-resistant gram-negative bacteria in India. The partnership aims...
Feb 25, 2025 12:18

More News for Venus Remedies Ltd. »

News for Pharmaceuticals and health care

EPFO Automates Retirement Fund Withdrawals
EPFO to automate final PF withdrawals, speeding up money transfers. Auto-settlement & auto-transfer of PF accounts on job change coming soon.
May 13, 2026 16:29
Gold Duty Hike: Impact on Volumes & Recycling
Jewellers assess the impact of the gold import duty hike on volumes, recycling, and the domestic gold economy in India.
May 13, 2026 16:25
Rupee Hits Record Low: USD Impact & RBI Actions
Rupee crashes to a record low of 95.80 against the USD. Explore the factors, RBI intervention, and market analysis.
May 13, 2026 16:18
Stock Markets End Higher After Losses
Sensex and Nifty snap four days of losses, closing marginally higher. Crude oil prices and geopolitical factors limit gains.
May 13, 2026 16:09
GSK Pharma Q4 Profit Up 5.7% to Rs 277.86 Cr
GSK Pharma reports a 5.7% rise in Q4 net profit to Rs 277.86 crore. Revenue and expenses also increased. Final dividend declared.
May 13, 2026 15:47

More News »

Top News

Paddy MSP Hiked; Sunflower Seed Sees Biggest Rise
Govt increases paddy MSP by Rs 72. Sunflower seed gets the highest hike. See new MSPs for pulses, oilseeds, cotton, and cereals.
May 13, 2026 16:30
EPFO Automates Retirement Fund Withdrawals
EPFO to automate final PF withdrawals, speeding up money transfers. Auto-settlement & auto-transfer of PF accounts on job change coming soon.
May 13, 2026 16:29
Gold Duty Hike: Impact on Volumes & Recycling
Jewellers assess the impact of the gold import duty hike on volumes, recycling, and the domestic gold economy in India.
May 13, 2026 16:25
Nagpur Airport Upgradation Approved
Cabinet approves Nagpur International Airport upgradation via PPP. Lease extended, GMR to operate. Expect improved services.
May 13, 2026 16:19
Rupee Hits Record Low: USD Impact & RBI Actions
Rupee crashes to a record low of 95.80 against the USD. Explore the factors, RBI intervention, and market analysis.
May 13, 2026 16:18

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com